{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T15:06:30Z","timestamp":1776179190454,"version":"3.50.1"},"reference-count":37,"publisher":"Informa UK Limited","issue":"19","license":[{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007345","name":"University of Arizona Cancer Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007345","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100020540","name":"Coherus BioSciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020540","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.2217\/fon-2022-0166","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T08:51:59Z","timestamp":1651135919000},"page":"2381-2390","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Retrospective evaluation of safety and effectiveness of same-day pegfilgrastim in patients with lung cancer"],"prefix":"10.1080","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4663-1831","authenticated-orcid":false,"given":"Neda","family":"Alrawashdh","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice & Science, College of Pharmacy,University of Arizona,\rTucson,\rAZ 85721,\rUSA"},{"name":"Department of Health Sciences, College of Medicine,University of Arizona,\rTucson,\rAZ 85724,\rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie","family":"Vraney","sequence":"additional","affiliation":[{"name":"The University of Arizona College of Pharmacy\/Banner,University Medical Center Tucson,\rTucson,\rAZ 85721,\rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Briana M","family":"Choi","sequence":"additional","affiliation":[{"name":"Center for Health Outcomes & PharmacoEconomic Research,University of Arizona,\rTucson,\rAZ 85721,\rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulaali R","family":"Almutairi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice & Science, College of Pharmacy,University of Arizona,\rTucson,\rAZ 85721,\rUSA"},{"name":"Drug Sector,Saudi Food & Drug Authority,\rRiyadh,\r13513-7148,\rSaudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0490-4421","authenticated-orcid":false,"given":"Ivo","family":"Abraham","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice & Science, College of Pharmacy,University of Arizona,\rTucson,\rAZ 85721,\rUSA"},{"name":"Center for Health Outcomes & PharmacoEconomic Research,University of Arizona,\rTucson,\rAZ 85721,\rUSA"},{"name":"The University of Arizona Cancer Center,\rTucson,\rAZ 85719,\rUSA"},{"name":"Clinical Translational Sciences, College of Medicine,University of Arizona,\rTucson,\rAZ 85724,\rUSA"},{"name":"Matrix45,\rTucson,\rAZ 85743,\rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9430-4675","authenticated-orcid":false,"given":"Ali","family":"McBride","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice & Science, College of Pharmacy,University of Arizona,\rTucson,\rAZ 85721,\rUSA"},{"name":"The University of Arizona College of Pharmacy\/Banner,University Medical Center Tucson,\rTucson,\rAZ 85721,\rUSA"},{"name":"Center for Health Outcomes & PharmacoEconomic Research,University of Arizona,\rTucson,\rAZ 85721,\rUSA"},{"name":"The University of Arizona Cancer Center,\rTucson,\rAZ 85719,\rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,4,28]]},"reference":[{"key":"e_1_3_7_3_1","unstructured":"World Health Organization . Cancer Fact Sheet (2022). www.who.int\/news-room\/fact-sheets\/detail\/cancer"},{"key":"e_1_3_7_4_1","unstructured":"Centers for Disease Control and Prevention . Cancer statistics at a glance. https:\/\/gis.cdc.gov\/Cancer\/USCS\/#\/AtAGlance\/"},{"key":"e_1_3_7_5_1","unstructured":"American Cancer Society . Key statistics for lung cancer (2022). www.cancer.org\/cancer\/lung-cancer\/about\/key-statistics.html"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9051362"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omto.2019.02.001"},{"key":"e_1_3_7_8_1","unstructured":"National Comprehensive Cancer Network . NCCN practice guidelines in Oncology. Hematopoietic growth factors. Version 1.2022. Plymouth Meeting PA USA (2021). www.nccn.org\/guidelines\/guidelines-detail?category=3&id=1493"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2016.019588"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2010.10.013"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-018-4373-0"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.091094"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2017.1386858"},{"key":"e_1_3_7_14_1","unstructured":"Neulasta\u00a9(pegfilgrastim) injection for subcutaneous use package insert. Amgen Inc CA USA (2021)."},{"key":"e_1_3_7_15_1","doi-asserted-by":"crossref","unstructured":"Stuessy P SanchezFA SchoberM. Retrospective review of pegfilgrastim on-body injector delivery rates in a large health system. 35(Suppl. 15) e18273\u2013e18273 (2017).","DOI":"10.1200\/JCO.2017.35.15_suppl.e18273"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1188\/17.CJON.121-122"},{"issue":"3","key":"e_1_3_7_17_1","first-page":"119","article-title":"Comparing grade 4 neutropenia associated with pegfilgrastim administered via the Onpro device versus manual injection with a prefilled syringe","volume":"8","author":"Townley C","year":"2018","unstructured":"Townley C , PorterC, McmullenN. Comparing grade 4 neutropenia associated with pegfilgrastim administered via the Onpro device versus manual injection with a prefilled syringe. J. Hematol. Oncol. Pharm.8(3), 119\u2013125 (2018).","journal-title":"J. Hematol. Oncol. Pharm."},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.62.3488"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-017-3703-y"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-016-2970-5"},{"key":"e_1_3_7_21_1","unstructured":"U.S. Centers for Medicare & Medicaid Services . Drug coverage under different parts of Medicare. (2021). www.cms.gov\/outreach-and-education\/outreach\/partnerships\/downloads\/11315-p.pdf"},{"key":"e_1_3_7_22_1","unstructured":"Fulphila\u00ae (pegfilgrastim-jmdb) injection for subcutaneous use package insert. Mylan Institutional LLC IL USA (2021)."},{"key":"e_1_3_7_23_1","unstructured":"Udenyca\u00ae (pegfilgrastim-cbqv) injection for subcutaneous use package insert. Coherus Biosciences CA USA (2021)."},{"key":"e_1_3_7_24_1","unstructured":"Ziextenzo\u00ae (pegfilgrastim-bmez) injection for subcutaneous use package insert. Sandoz Inc NJ USA (2021)."},{"key":"e_1_3_7_25_1","unstructured":"Nyvepria\u2122 (pegfilgrastim-apgf) injection for subcutaneous use package insert. Hospira Inc. a Pfizer Company IL USA2021)."},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-018-4513-6"},{"key":"e_1_3_7_27_1","unstructured":"National Comprehensive Cancer Network . NCCN hematopoietic growth factors. short-term recommendations specific to issues with COVID-19 (SARS-CoV-2). Plymouth Meeting PA USA (2020). www.iononline.com\/-\/media\/assets\/ion\/pdf\/covid19-resources\/nccn_hgf_covid-19_19may20.pdf?la=en&hash=9FB98741E9E83D354F8FEFF66AC5F5188E139471"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1177\/1078155220956305"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2021-0532"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-020-05982-0"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2016.12.003"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000000115"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2007.25.18_suppl.19636"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000487"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3227"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-015-3036-7"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/07357900500276899"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.39.28_suppl.71"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2020-0213"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2022-0166","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:43:37Z","timestamp":1719125017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2022-0166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":37,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10.2217\/fon-2022-0166"],"URL":"https:\/\/doi.org\/10.2217\/fon-2022-0166","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-02-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}